GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition (Q39606314)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 January 2011
edit
Language Label Description Also known as
English
GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition
scientific article published on 18 January 2011

    Statements

    GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition (English)
    Aidan G Gilmartin
    Maureen R Bleam
    Arthur Groy
    Katherine G Moss
    Elisabeth A Minthorn
    Swarupa G Kulkarni
    Cynthia M Rominger
    Symon Erskine
    Kelly E Fisher
    Jingsong Yang
    Francesca Zappacosta
    Roland Annan
    David Sutton
    Sylvie G Laquerre
    18 January 2011
    989-1000

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit